Oxford’s Healthcare Real Estate Group Closes More than $867MM in Capital Commitments in 2022

Oxford Finance and its healthcare real estate group closed a company record level of originations in 2022, with Oxford providing more than $867 million of capital commitments. The group closed a total of 14 transactions, with credit facilities ranging from $9 million to over $124 million.

February 3, 2023 Oxford Finance Ian Koplin

Oxford Finance Closes $115MM Senior Credit Facility to Pearl Street Dental Partners

Oxford Finance, a specialty finance firm focused on healthcare services and life sciences companies worldwide, closed a $115 million senior credit facility to Pearl Street Dental Partners, a dental platform owned by SkyKnight Capital, dentists and management.

November 17, 2022 David Meece | Jordan Milich | Oxford Finance | Pearl Street Dental Partners | SkyKnight Capital | Tracy S. Maziek Ian Koplin

Oxford Finance and SVB Supply $100MM in Financing to ALX Oncology

ALX Oncology, a clinical-stage immuno-oncology company, entered into a loan facility agreement with Oxford Finance and Silicon Valley Bank for up to $100 million of non-dilutive financing.

November 1, 2022 AXL Oncology | Christopher A. Herr | Oxford Finance | Peter Garcia | Silicon Valley Bank Phil Neuffer

Oxford Finance Provides $1.24.75MM Credit Facility Supporting Autumn Lake Healthcare Acquisitions

Oxford Finance, a specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, closed a $124.75 million senior credit facility for the acquisition of four Autumn Lake Healthcare skilled nursing facilities located in Maryland containing 520 licensed beds.

October 21, 2022 Autumn Lake Healthcare | Mark Schwartz | Oxford Finance | Tracy S. Maziek Ian Koplin

Oxford Finance Provides $150MM Debt Financing to Verona Pharma

Verona Pharma entered into a debt financing facility providing the company with access to up to $150 million from Oxford Finance. The $150 million debt facility replaces the existing $30 million facility with Silicon Valley Bank.

October 17, 2022 Adam K. Soller | David Zaccardelli | Oxford Finance | Silicon Valley Bank | Verona Pharma Ian Koplin

Madryn Asset Management Supports Greenbrook TMS with $75MM Credit Facility

Greenbrook TMS closed its acquisition of Check Five, a Delaware limited liability company. In addition, Greenbrook entered into a credit agreement for a $75 million secured credit facility with Madryn Asset Management and its affiliated entities.

July 15, 2022 Bill Leonard | Bloom Burton Securities | Check Five | Dr. Avinash Amin | Greenbrook TMS | Madryn Asset Management | Oxford Finance Ian Koplin

Oxford Financial Closes $125MM Debt Facility with RefleXion Medical

RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy for all stages of cancer, closed a $125 million debt facility with Oxford Financial, of which $55 million is available immediately to repay the company’s existing $50 million of debt.

July 7, 2022 Christopher A. Herr | Martyn Webster | Oxford Finance | RefleXion Medical Ian Koplin

Oxford Finance Closes $30MM Selux Diagnostics Credit Facility

Oxford Finance closed a $30 million senior secured term loan with Selux Diagnostic, a Boston-based medical device company focused on personalized diagnostics to combat superbug infections and fight antibiotic resistance.

June 2, 2022 Christopher A. Herr | Oxford Finance | Selux Diagnostic | Steve Lufkin Rita Garwood

Oxford Finance Provides $250MM in Debt Financing to Silk Road Medical

Silk Road Medical, a company focused on reducing the risk of stroke, entered into a five-year loan arrangement with Oxford Finance comprising up to a $200 million term loan and up to a $50 million revolving line of credit.

June 1, 2022 Armentum Partners | Lucas Buchanan | Oxford Finance | Silk Road Medical Ian Koplin

Oxford Finance Provides $100MM Loan Facility to Pliant Therapeutics

Pliant Therapeutics, a clinical stage biotechnology company, entered into a loan facility agreement with Oxford Finance for up to $100 million of non-dilutive financing.

May 6, 2022 Keith Cummings | Oxford Finance | Pliant Therapeutics Ian Koplin